AFP Gastric or Gastroesophageal Junction Adenocarcinoma Clinical Trials in Shijiazhuang, Hebei

Iparomlimab and Tuvonralimab Combined With Apatinib and Irinotecan Hydrochloride for the Treatment of Advanced Alpha-fetoprotein-producing Gastric Cancer (AFPGC)